Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Osteoporosis

Free Subscription Articles published in Lancet Retrieve available abstracts of 8 articles: HTML format

Single Articles

January 2019
1. COMPSTON JE, McClung MR, Leslie WD
   Osteoporosis.
   Lancet. 2019;393:364-376.
   PubMed     Abstract available
   
   
   May 2018
2. KENDLER DL, Geusens P, Zerbini CAF, Minisola S, et al
   Teriparatide vs risedronate for osteoporosis - Authors' reply.
   Lancet. 2018;391:1896.
   PubMed    
   
   
   
3. LIEL Y
   Teriparatide vs risedronate for osteoporosis.
   Lancet. 2018;391:1895.
   PubMed    
   
   
   November 2017
4. HARVEY NC, McCloskey E, Kanis JA, Compston J, et al
   Bisphosphonates in osteoporosis: NICE and easy?
   Lancet. 2017;390:2243-2244.
   PubMed    
   
   
   
5. FERRARI SL
   Prevention of fractures in patients with osteoporosis.
   Lancet. 2017 Nov 9. pii: S0140-6736(17)32167.
   PubMed    
   
   
   
6. KENDLER DL, Marin F, Zerbini CAF, Russo LA, et al
   Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.
   Lancet. 2017 Nov 9. pii: S0140-6736(17)32137.
   PubMed     Abstract available
   
   
   July 2017
7. LANGDAHL BL, Libanati C, Crittenden DB, Bolognese MA, et al
   Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial.
   Lancet. 2017 Jul 26. pii: S0140-6736(17)31613.
   PubMed     Abstract available
   
   
   
8. COMPSTON J
   Bone-forming agents in non-responders to bisphosphonates.
   Lancet. 2017 Jul 26. pii: S0140-6736(17)31824.
   PubMed    
   
   

Thank you for your interest in scientific medicine.

AMEDEO Osteoporosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: